Polygonum Aviculare L . Extract and Quercetin Attenuate Contraction in Airway Smooth Muscle
Xi Luo,Lu Xue,Hao Xu,Qing-Yang Zhao,Qian Wang,Yu-Shan She,Dun-An Zang,Jinhua Shen,Yong-Bo Peng,Ping Zhao,Meng-Fei Yu,Weiwei Chen,Li-Qun Ma,Shu Chen,Shanshan Chen,Xiangning Fu,Sheng Hu,Xiaowei Nie,Chenyou Shen,Chunbin Zou,Gangjian Qin,Jiapei Dai,Guangju Ji,Yunchao Su,Shen Hu,Jingyu Chen,Qing-Hua Liu
DOI: https://doi.org/10.1038/s41598-018-20409-x
IF: 4.6
2018-01-01
Scientific Reports
Abstract:Because of the serious side effects of the currently used bronchodilators, new compounds with similar functions must be developed. We screened several herbs and found that Polygonum aviculare L . contains ingredients that inhibit the precontraction of mouse and human airway smooth muscle (ASM). High K + -induced precontraction in ASM was completely inhibited by nifedipine, a selective blocker of L-type voltage-dependent Ca 2+ channels (LVDCCs). However, nifedipine only partially reduced the precontraction induced by acetylcholine chloride (ACH). Additionally, the ACH-induced precontraction was partly reduced by pyrazole-3 (Pyr3), a selective blocker of TRPC3 and stromal interaction molecule (STIM)/Orai channels. These channel-mediated currents were inhibited by the compounds present in P . aviculare extracts, suggesting that this inhibition was mediated by LVDCCs, TRPC3 and/or STIM/Orai channels. Moreover, these channel-mediated currents were inhibited by quercetin, which is present in P . aviculare extracts. Furthermore, quercetin inhibited ACH-induced precontraction in ASM. Overall, our data indicate that the ethyl acetate fraction of P . aviculare and quercetin can inhibit Ca 2+ -permeant LVDCCs, TRPC3 and STIM/Orai channels, which inhibits the precontraction of ASM. These findings suggest that P . aviculare could be used to develop new bronchodilators to treat obstructive lung diseases such as asthma and chronic obstructive pulmonary disease.